Bone Health Technologies has closed a $2.5 million funding round and appointed three members to its Board of DIrectors: Karen Drexler; Nancy Lynch, M.D.; and Sam Goldberger, M.D.
“Our mission is to provide an effective and safe treatment for the more than 40 million Americans with low bone density. This capital and the expertise we are bringing to bear is exactly what we need to complete our pivotal trial and bring this important innovation to market,” said Laura Yecies, CEO of Bone Health Technologies (BHT).
“We have been involved with Bone Health Technologies since the early proof of concept stage and are thrilled to lead this investment round—the unmet need and hence the business opportunity is enormous” said John Osborne, managing partner, Good Growth Capital. Good Growth Capital led the oversubscribed funding round, which includes investments by Astia Angels, Ambit Health Ventures, Portfolia Femtech Fund, IT-Farm, Golden Seeds, Berkeley Angel Network, the Band of Angels, and Reno Seed Fund as well as prominent individual angel Investors.